Migraine treatment and placebo effect

被引:26
作者
Speciali, Jose G. [1 ]
Peres, Mario [2 ]
Bigal, Marcelo E. [3 ,4 ]
机构
[1] Univ Sao Paulo, Dept Neurol, Sch Med Ribeirao Preto, Sao Paulo, Brazil
[2] Albert Einstein Med Hosp, Div Neurol, Sao Paulo, Brazil
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[4] Merck Res Labs, Whitehouse Stn, NJ USA
关键词
acute treatment; migraine; placebo; placebo effect; preventive treatment; BLIND CLINICAL-TRIALS; TOXIN TYPE-A; PROPHYLACTIC TREATMENT; PARALLEL-GROUP; MULTICENTER; HEADACHE; ACUPUNCTURE; MECHANISMS; ANALGESIA; EFFICACY;
D O I
10.1586/ERN.10.8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Placebos are typically defined as physiologically inactive substances that elicit a therapeutic response. The antipode of the placebo effect is the nocebo effect, or the negative effects of placebo, where unpleasant symptoms (e.g., adverse events) emerge after the administration of placebo. Placebo analgesia is one of the most striking examples of the cognitive modulation of pain perception. Herein we focus on the importance of placebo in headache research. We first review the mechanisms of the placebo effect. We then focus on the importance of placebo in the acute treatment of migraine. We follow by discussing the importance of placebo on the preventive treatment of migraine and our perspectives for the 5 years to come regarding the study of the placebos.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 50 条
  • [21] Recognition and treatment of menstrual migraine
    Lay, Christine L.
    Payne, Richard
    NEUROLOGIST, 2007, 13 (04) : 197 - 204
  • [22] White matter tract microstructure of the mPFC-amygdala predicts interindividual differences in placebo response related to treatment in migraine patients
    Liu, Jixin
    Mu, Junya
    Chen, Tao
    Zhang, Ming
    Tian, Jie
    HUMAN BRAIN MAPPING, 2019, 40 (01) : 284 - 292
  • [23] Preventing the Progression of Episodic Migraine to Chronic Migraine with Acute Treatment Optimization
    Kuruvilla, Deena E.
    Bilchik, Tanya
    CURRENT PAIN AND HEADACHE REPORTS, 2022, 26 (03) : 253 - 258
  • [24] Botulinum toxin type A in migraine prophylaxis:: Placebo effect or efficacy?
    Kueper, Michael
    Diener, H. C.
    AKTUELLE NEUROLOGIE, 2007, 34 (08) : 464 - 465
  • [25] The acute and preventative treatment of episodic migraine
    Miller, Sarah
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2012, 15 : 33 - 39
  • [26] Novel synthetic treatment options for migraine
    Negro, Andrea
    Martelletti, Paolo
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (07) : 907 - 922
  • [27] OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    CURRENT PAIN AND HEADACHE REPORTS, 2011, 15 (01) : 4 - 7
  • [28] Advances in topiramate as prophylactic treatment for migraine
    Hu, Chuan
    Zhang, Yixin
    Tan, Ge
    BRAIN AND BEHAVIOR, 2021, 11 (10):
  • [29] Intravenous Migraine Treatment in Children and Adolescents
    Werner, Klaus G.
    Qaiser, Sharoon
    Kabbouche, Marielle A.
    Murphy, Beverly
    Maconochie, Ian
    Hershey, Andrew D.
    CURRENT PAIN AND HEADACHE REPORTS, 2020, 24 (08)
  • [30] Nutraceuticals in Acute and Prophylactic Treatment of Migraine
    Daniel, Oved
    Mauskop, Alexander
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (04) : 1 - 8